Last reviewed · How we verify
NCT04243889
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
NA trial testing NEOX Cord 1K in Spina Bifida in 50 participants. Participants enrolled and being followed up; not accepting new ones.
30 May 2023
Quick facts
| Lead sponsor | The University of Texas Health Science Center, Houston |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 28 August 2020 |
| Primary completion | 30 May 2023 |
| Estimated completion | 12 March 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NEOX Cord 1K
Conditions studied
- Spina Bifida — all drugs for Spina Bifida →
- Myelomeningocele — all drugs for Myelomeningocele →
- Myeloschisis — all drugs for Myeloschisis →
Sponsor
The University of Texas Health Science Center, Houston
Who can join
18 and older, any sex, with Spina Bifida or Myelomeningocele. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For larger skin defects, NEOX Cord 1K® may be used as a skin cover.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Fetoscopic Myelomeningocele (MMC) Repair: Evolution of the Technique and a Call for Standardization.
Cruz SM, Hameedi S, Sbragia L, Ogunleye O, et al · · 2025 · cited 2× · PMID 40094785 · DOI 10.3390/jcm14051402 -
Evolution and Variations of the Ovine Model of Spina Bifida.
Lee SY, Du Y, Hassan AS, Brown E, et al · · 2023 · cited 1× · PMID 37393899 · DOI 10.1159/000531750 -
Morphometric analysis of spina bifida after fetal repair shows new subtypes with associated outcomes.
Mann LK, Pandiri S, Agarwal N, Northrup H, et al · · 2025 · PMID 40848293 · DOI 10.1002/uog.70035
Verify or expand the search:
- PubMed search for NCT04243889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spina Bifida
Currently open trials in the same condition.
- NCT06723951 — QUALAS Validation in Dutch · recruiting
- NCT06041334 — Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up · NA · recruiting
- NCT06802770 — Evaluation of Depression and Anxiety Levels of Parents of Children with Spina Bifida · active not recruiting
- NCT05726591 — Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Dis · NA · recruiting
- NCT05339932 — Grand Valley State University (GVSU) Skills on Wheels · NA · active not recruiting
Other The University of Texas Health Science Center, Houston trials
Trials by the same sponsor.
- NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
- NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
- NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
- NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
- NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04243889 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04243889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing